San Diego, CA, United States of America

Trevor R F Smith


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Trevor R. F. Smith

Introduction

Trevor R. F. Smith, an innovative inventor based in San Diego, CA, has made significant contributions to the field of biotechnology. With a total of two patents to his name, his work primarily focuses on developing antibodies to combat viral infections, particularly the Middle East Respiratory Syndrome Coronavirus (MERS-CoV).

Latest Patents

Smith's latest patents detail a composition that includes a recombinant nucleic acid sequence encoding an antibody to a MERS-CoV viral antigen. The patents disclose a method for generating a synthetic antibody within a subject by administering the composition, aiming to prevent and/or treat MERS-CoV infections. This groundbreaking research has the potential to significantly enhance therapeutic strategies against this serious viral threat.

Career Highlights

Throughout his career, Trevor R. F. Smith has been associated with notable institutions, including The Wistar Institute of Anatomy & Biology and Inovio Pharmaceuticals, Inc. His experience at these organizations has bolstered his expertise in the development of advanced therapeutic solutions for viral infections, helping to pave the way for future innovations in medicine.

Collaborations

Smith has collaborated with esteemed colleagues in the field, including David B. Weiner and Kar Muthumani. Their partnerships have likely contributed to the success of Smith's inventive projects and the furthering of research in antibody development.

Conclusion

Trevor R. F. Smith stands out as a pioneering inventor dedicated to addressing pressing health challenges through his innovative patents. His contributions to the fight against coronavirus infections illustrate the vital role of inventors in advancing medical science and public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…